Phase II trial of biweekly CPT-11 plus CDDP for patients with unresectable or recurrent gastric cancer refractory to S-1.
Y. Rino
No relevant relationships to disclose
T. Oshima
No relevant relationships to disclose
N. Yukawa
No relevant relationships to disclose
R. Yamada
No relevant relationships to disclose
T. Sato
No relevant relationships to disclose
M. Takahashi
No relevant relationships to disclose
H. Matsukawa
No relevant relationships to disclose
Y. Yamamoto
No relevant relationships to disclose
R. Shiraishi
No relevant relationships to disclose
M. Masuda
No relevant relationships to disclose
T. Imada
No relevant relationships to disclose